Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2017

06.10.2016 | Review

Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies

verfasst von: Joseph Menczer

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Platelets have multiple functions and they also play an important role in malignancies. Elevated platelet count and thrombocytosis at the time of diagnosis in patients with many solid tumors correlates with prognosis and is associated with poor survival. The aim of the following report is to review the literature concerning elevated platelet count and thrombocytosis in gynecologic malignancies.

Method

A PubMed search of all English literature peer-reviewed publications was performed containing the terms elevated platelet count or thrombocytosis and vulvar cancer, cervical cancer, endometrial cancer, and ovarian cancer. All studies published until December 31, 2015, were included in the following review.

Results

A pretreatment elevated platelet count and thrombocytosis have been shown to be associated with a poor prognosis in many studies of gynecologic malignancies with the exception of vulvar carcinoma.

Conclusion

Since elevated platelet count and thrombocytosis may be prevented by blocking thrombopoietic cytokines, their assessment may, in the future, be of therapeutic significance.
Literatur
1.
Zurück zum Zitat Buergy D, Wenz F, Groden C, Brockmann MA (2009) Tumor-platelet interaction in solid tumors. Int J Cancer 130:2747–2760CrossRef Buergy D, Wenz F, Groden C, Brockmann MA (2009) Tumor-platelet interaction in solid tumors. Int J Cancer 130:2747–2760CrossRef
3.
Zurück zum Zitat Lavie O, Comerci G, Daras V, Bolger BS, Lopes A, Monaghan JM (1999) Thrombocytosis in women with vulvar carcinoma. Gynecol Oncol 72:82–86CrossRefPubMed Lavie O, Comerci G, Daras V, Bolger BS, Lopes A, Monaghan JM (1999) Thrombocytosis in women with vulvar carcinoma. Gynecol Oncol 72:82–86CrossRefPubMed
4.
Zurück zum Zitat Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C et al (2000) Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21:309–314CrossRefPubMed Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C et al (2000) Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21:309–314CrossRefPubMed
5.
Zurück zum Zitat Rodriguez GC, Clarke-Pearson DL, Soper JT, Berchuck A, Synan I, Dodge RK (1994) The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol 83:445–448PubMed Rodriguez GC, Clarke-Pearson DL, Soper JT, Berchuck A, Synan I, Dodge RK (1994) The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol 83:445–448PubMed
6.
Zurück zum Zitat Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J (1992) Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 69:2975–2977CrossRefPubMed Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J (1992) Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 69:2975–2977CrossRefPubMed
7.
Zurück zum Zitat Hernandez E, Heller PB, Whitney C, Diana K, Delgado G (1994) Thrombocytosis in surgically treated stage IB squamous cell cervical carcinoma (a gynecologic oncology group study). Gynecol Oncol 55:328–332CrossRefPubMed Hernandez E, Heller PB, Whitney C, Diana K, Delgado G (1994) Thrombocytosis in surgically treated stage IB squamous cell cervical carcinoma (a gynecologic oncology group study). Gynecol Oncol 55:328–332CrossRefPubMed
8.
Zurück zum Zitat Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB (2000) The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a gynecologic oncology group study. Gynecol Oncol 78:137–142CrossRefPubMed Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB (2000) The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a gynecologic oncology group study. Gynecol Oncol 78:137–142CrossRefPubMed
9.
Zurück zum Zitat De Jonge ET, Viljoen E, Lindeque BG, Amant F, Nesland JM, Holm R (1999) The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy. Int J Gynecol Cancer 9:198–205CrossRefPubMed De Jonge ET, Viljoen E, Lindeque BG, Amant F, Nesland JM, Holm R (1999) The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy. Int J Gynecol Cancer 9:198–205CrossRefPubMed
10.
Zurück zum Zitat Lopes A, Daras V, Cross PA, Robertson G, Beynon G, Monaghan JM (1994) Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer 74:90–92CrossRefPubMed Lopes A, Daras V, Cross PA, Robertson G, Beynon G, Monaghan JM (1994) Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer 74:90–92CrossRefPubMed
11.
Zurück zum Zitat Zhao K, Deng H, Qin Y, Liao W, Liang W (2015) Prognostic significance of pretreatment plasma fibrinogen and platelet levels in patients with early-stage cervical cancer. Gynecol Obstet Invest 79:25–33CrossRefPubMed Zhao K, Deng H, Qin Y, Liao W, Liang W (2015) Prognostic significance of pretreatment plasma fibrinogen and platelet levels in patients with early-stage cervical cancer. Gynecol Obstet Invest 79:25–33CrossRefPubMed
12.
Zurück zum Zitat Menczer J, Geva D, Schejter E, Zakut H (1996) Elevated platelet count in patients with endometrial carcinoma: correlation with selected prognostic factors and with survival. Int J Gynecol Cancer 6:463–466CrossRef Menczer J, Geva D, Schejter E, Zakut H (1996) Elevated platelet count in patients with endometrial carcinoma: correlation with selected prognostic factors and with survival. Int J Gynecol Cancer 6:463–466CrossRef
13.
Zurück zum Zitat Gücer F, Moser F, Tamussino K, Reich O, Haas J, Arikan G et al (1998) Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 70:210–214CrossRefPubMed Gücer F, Moser F, Tamussino K, Reich O, Haas J, Arikan G et al (1998) Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 70:210–214CrossRefPubMed
14.
Zurück zum Zitat Ayhan A, Bozdag G, Taskiran C, Gultekin M, Yuce K, Kucukali T (2006) The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. Gynecol Oncol 103:902–905CrossRefPubMed Ayhan A, Bozdag G, Taskiran C, Gultekin M, Yuce K, Kucukali T (2006) The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. Gynecol Oncol 103:902–905CrossRefPubMed
15.
Zurück zum Zitat Gorelick C, Andikyan V, Mack M, Lee YC, Abulafia O (2009) Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer 19:1384–1389CrossRefPubMed Gorelick C, Andikyan V, Mack M, Lee YC, Abulafia O (2009) Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer 19:1384–1389CrossRefPubMed
16.
Zurück zum Zitat Heng S, Benjapibal M (2014) Preoperative thrombocytosis and poor prognostic factors in endometrial cancer. Asian Pac J Cancer Prev 15:10231–10236CrossRefPubMed Heng S, Benjapibal M (2014) Preoperative thrombocytosis and poor prognostic factors in endometrial cancer. Asian Pac J Cancer Prev 15:10231–10236CrossRefPubMed
17.
Zurück zum Zitat Tamussino KF, Gucer F, Reich O, Moser F, Petru E, Scholz HS (2001) Pretreatment hemoglobin, platelet count and prognosis in endometrial carcinoma. Int J Gynecol Cancer 1(11):236–240CrossRef Tamussino KF, Gucer F, Reich O, Moser F, Petru E, Scholz HS (2001) Pretreatment hemoglobin, platelet count and prognosis in endometrial carcinoma. Int J Gynecol Cancer 1(11):236–240CrossRef
18.
Zurück zum Zitat Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ (2007) The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol 104:91–94CrossRefPubMed Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ (2007) The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol 104:91–94CrossRefPubMed
19.
Zurück zum Zitat Scholz HS, Petru E, Gucer F, Haas J, Tamussino K et al (2000) Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20:3983–3985PubMed Scholz HS, Petru E, Gucer F, Haas J, Tamussino K et al (2000) Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20:3983–3985PubMed
20.
Zurück zum Zitat Metindir J, Dilek GB (2009) Preoperatiove hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. J Cancer Res Clin Oncol 135:125–129CrossRefPubMed Metindir J, Dilek GB (2009) Preoperatiove hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. J Cancer Res Clin Oncol 135:125–129CrossRefPubMed
21.
Zurück zum Zitat Kaloglu S, Guraslan H, Tekirdag AI, Dagdeviren H, Kaya C (2014) Relation of preoperative thrombocytosis between tumor stage and grade in patients with endometrial carcinoma. Eurasian J Med 46:164–168CrossRefPubMedPubMedCentral Kaloglu S, Guraslan H, Tekirdag AI, Dagdeviren H, Kaya C (2014) Relation of preoperative thrombocytosis between tumor stage and grade in patients with endometrial carcinoma. Eurasian J Med 46:164–168CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Gastl G, Plante M, Finstad CL, Wong GY, Federici MG, Bander NH et al (1993) High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 83:433–441CrossRefPubMed Gastl G, Plante M, Finstad CL, Wong GY, Federici MG, Bander NH et al (1993) High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 83:433–441CrossRefPubMed
23.
Zurück zum Zitat Menczer J, Schejter E, Geva D, Ginath S, Zakut H (1998) Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 19:82–84PubMed Menczer J, Schejter E, Geva D, Ginath S, Zakut H (1998) Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 19:82–84PubMed
24.
Zurück zum Zitat Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92:211–214CrossRefPubMed Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92:211–214CrossRefPubMed
25.
Zurück zum Zitat Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J et al (2012) Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366:610–618CrossRefPubMedPubMedCentral Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J et al (2012) Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366:610–618CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Gerestein CG, Eijkemans MJ, de Jong D, van der Burg ME, Dykgraaf RH, Kooi GS et al (2009) The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG 116:372–380CrossRefPubMed Gerestein CG, Eijkemans MJ, de Jong D, van der Burg ME, Dykgraaf RH, Kooi GS et al (2009) The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG 116:372–380CrossRefPubMed
27.
Zurück zum Zitat Kuyumcuoglu U, Guzel AI, Celik Y, Erdemoğlu M (2010) The association of preoperative thrombocytosis with prognostic factors in malignant ovarian tumor. Eur J Gynecol Oncol 31:514–516 Kuyumcuoglu U, Guzel AI, Celik Y, Erdemoğlu M (2010) The association of preoperative thrombocytosis with prognostic factors in malignant ovarian tumor. Eur J Gynecol Oncol 31:514–516
28.
Zurück zum Zitat Gastl G, Plante M (2001) Bioactive interleukin-6 levels in serum and ascites as a. Methods Mol Med 39:121–123PubMed Gastl G, Plante M (2001) Bioactive interleukin-6 levels in serum and ascites as a. Methods Mol Med 39:121–123PubMed
29.
Zurück zum Zitat Bakkum-Gamez JN, Langstraat CL, Martin JR, Lemens MA, Weaver AL, Allensworth S et al (2012) Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma. Gynecol Oncol 125:614–620CrossRefPubMedPubMedCentral Bakkum-Gamez JN, Langstraat CL, Martin JR, Lemens MA, Weaver AL, Allensworth S et al (2012) Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma. Gynecol Oncol 125:614–620CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Cohen JG, Tran AQ, Rimel BJ, Cass I, Walsh CS, Karlan BY et al (2014) Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival. Gynecol Oncol 132:556–559CrossRefPubMed Cohen JG, Tran AQ, Rimel BJ, Cass I, Walsh CS, Karlan BY et al (2014) Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival. Gynecol Oncol 132:556–559CrossRefPubMed
31.
Zurück zum Zitat Zeimet AG, Marth C, Müller-Holzner E, Daxenbichler G, Dapunt O (1994) Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170:549–554CrossRefPubMed Zeimet AG, Marth C, Müller-Holzner E, Daxenbichler G, Dapunt O (1994) Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170:549–554CrossRefPubMed
32.
Zurück zum Zitat Chalas E, Welshinger M, Engellener W, Chumas J, Barbieri R, Mann WJ (1992) The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 166:974–977CrossRefPubMed Chalas E, Welshinger M, Engellener W, Chumas J, Barbieri R, Mann WJ (1992) The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 166:974–977CrossRefPubMed
33.
Zurück zum Zitat Guo Y, Nemeth J, O’Brien C, Susa M, Liu X, Zhang Z et al (2010) Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer. Clin Cancer Res 6:5759–5769CrossRef Guo Y, Nemeth J, O’Brien C, Susa M, Liu X, Zhang Z et al (2010) Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer. Clin Cancer Res 6:5759–5769CrossRef
34.
Zurück zum Zitat Egan K, Crowley D, Smyth P, O’Toole S, Spillane C, Martin C et al (2011) Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS ONE 6:e26125CrossRefPubMedPubMedCentral Egan K, Crowley D, Smyth P, O’Toole S, Spillane C, Martin C et al (2011) Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS ONE 6:e26125CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinste DA et al (2011) Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res 17:6083–6096CrossRefPubMedPubMedCentral Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinste DA et al (2011) Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res 17:6083–6096CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Andersen CL, Eskelund CW, Siersma VD, Felding P, Lind B, Palmblad J et al (2015) Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer? Gynecol Oncol 139:312–318CrossRefPubMed Andersen CL, Eskelund CW, Siersma VD, Felding P, Lind B, Palmblad J et al (2015) Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer? Gynecol Oncol 139:312–318CrossRefPubMed
Metadaten
Titel
Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies
verfasst von
Joseph Menczer
Publikationsdatum
06.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4212-9

Weitere Artikel der Ausgabe 1/2017

Archives of Gynecology and Obstetrics 1/2017 Zur Ausgabe

Correspondence

Answer to the editor

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.